These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 10690964)
1. HMG-CoA reductase inhibitors (statins): a promising approach to stroke prevention. Hess DC; Demchuk AM; Brass LM; Yatsu FM Neurology; 2000 Feb; 54(4):790-6. PubMed ID: 10690964 [TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. Lennernäs H; Fager G Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173 [TBL] [Abstract][Full Text] [Related]
3. Advantages of lipid-lowering therapy in cerebral ischemia: role of HMG-CoA reductase inhibitors. Gil-Núñez AC; Villanueva JA Cerebrovasc Dis; 2001; 11 Suppl 1():85-95. PubMed ID: 11244205 [TBL] [Abstract][Full Text] [Related]
4. How do HMG-CoA reductase inhibitors prevent stroke? Bedi A; Flaker GC Am J Cardiovasc Drugs; 2002; 2(1):7-14. PubMed ID: 14727994 [TBL] [Abstract][Full Text] [Related]
5. Statins in the treatment of acute ischemic stroke. Montecucco F; Quercioli A; Mirabelli-Badenier M; Viviani GL; Mach F Curr Pharm Biotechnol; 2012 Jan; 13(1):68-76. PubMed ID: 21470160 [TBL] [Abstract][Full Text] [Related]
6. Statins and stroke. Leys D; Deplanque D Therapie; 2003; 58(1):49-58. PubMed ID: 12822200 [TBL] [Abstract][Full Text] [Related]
8. [Statins in stroke prevention]. Gedikli O; Baykan M Anadolu Kardiyol Derg; 2008 Jun; 8(3):217-22. PubMed ID: 18524729 [TBL] [Abstract][Full Text] [Related]
9. Statins and stroke prevention. Paciaroni M; Hennerici M; Agnelli G; Bogousslavsky J Cerebrovasc Dis; 2007; 24(2-3):170-82. PubMed ID: 17596685 [TBL] [Abstract][Full Text] [Related]
10. HMG CoA reductase inhibitors (statins): use in stroke prevention and outcome after stroke. Moonis M; Fisher M Expert Rev Neurother; 2004 Mar; 4(2):241-7. PubMed ID: 15853565 [TBL] [Abstract][Full Text] [Related]
11. The relationship between cholesterol and stroke: implications for antihyperlipidaemic therapy in older patients. Sarti C; Kaarisalo M; Tuomilehto J Drugs Aging; 2000 Jul; 17(1):33-51. PubMed ID: 10933514 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of HMG-CoA reductase inhibitors in the prevention of cerebrovascular attack in 1016 patients older than 75 years among 4014 type 2 diabetic individuals. Hayashi T; Kubota K; Kawashima S; Sone H; Watanabe H; Ohrui T; Yokote K; Takemoto M; Araki A; Noda M; Noto H; Sakuma I; Yoshizumi M; Ina K; Nomura H; Int J Cardiol; 2014 Dec; 177(3):860-6. PubMed ID: 25466567 [TBL] [Abstract][Full Text] [Related]